Amy Webb

2.9k total citations · 2 hit papers
16 papers, 2.2k citations indexed

About

Amy Webb is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Amy Webb has authored 16 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Amy Webb's work include Liver Disease Diagnosis and Treatment (8 papers), Diet, Metabolism, and Disease (5 papers) and Pancreatitis Pathology and Treatment (3 papers). Amy Webb is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Diet, Metabolism, and Disease (5 papers) and Pancreatitis Pathology and Treatment (3 papers). Amy Webb collaborates with scholars based in United States, Australia and Canada. Amy Webb's co-authors include Kenneth Cusi, Romina Lomonaco, Beverly Orsak, Fernando Bril, Joan Hecht, Fermin O. Tio, Carolina Ortiz‐Lopez, Paola Portillo-Sánchez, Celia Darland and Jean Hardies and has published in prestigious journals such as Annals of Internal Medicine, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Amy Webb

15 papers receiving 2.2k citations

Hit Papers

Long-Term Pioglitazone Treatment for Patients With Nonalc... 2015 2026 2018 2022 2016 2015 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
    2016 737 citations Kenneth Cusi, Beverly Orsak et al. Annals of Internal Medicine profile →
  2. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
    2015 393 citations Paola Portillo-Sánchez, Fernando Bril et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Webb United States 13 1.7k 1.1k 519 442 356 16 2.2k
Francesco Baratta Italy 28 1.5k 0.9× 806 0.7× 442 0.9× 462 1.0× 602 1.7× 81 2.4k
Antonella Mosca Italy 23 1.5k 0.9× 848 0.8× 447 0.9× 294 0.7× 371 1.0× 82 2.1k
Muriel Webb Israel 21 1.8k 1.1× 1.2k 1.1× 517 1.0× 219 0.5× 648 1.8× 39 2.4k
Federico Salomone Italy 23 1.2k 0.7× 661 0.6× 410 0.8× 343 0.8× 377 1.1× 34 1.8k
Rita Manini Italy 14 2.9k 1.7× 1.8k 1.6× 708 1.4× 497 1.1× 589 1.7× 18 3.5k
Mangesh Pagadala United States 20 867 0.5× 460 0.4× 298 0.6× 253 0.6× 373 1.0× 35 1.4k
Mirja Tiikkainen Finland 14 1.1k 0.7× 1.1k 1.0× 123 0.2× 533 1.2× 555 1.6× 18 2.1k
Jennifer E. Lambert Canada 12 1.1k 0.7× 711 0.6× 152 0.3× 658 1.5× 694 1.9× 21 1.9k
G Smok Chile 25 981 0.6× 410 0.4× 339 0.7× 297 0.7× 310 0.9× 81 2.3k
Elena Paschetta Italy 18 748 0.4× 517 0.5× 222 0.4× 442 1.0× 259 0.7× 30 1.4k

Countries citing papers authored by Amy Webb

Since Specialization
Citations

This map shows the geographic impact of Amy Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Webb more than expected).

Fields of papers citing papers by Amy Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Webb. The network helps show where Amy Webb may publish in the future.

Co-authorship network of co-authors of Amy Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Webb. A scholar is included among the top collaborators of Amy Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Webb. Amy Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Patrick, Kevin, et al.. (2021). A Participatory Action Research (PAR) exploratory initiative for psychosis recovery and resilience. Psychosis. 13(2). 143–153. 2 indexed citations
2.
Cusi, Kenneth, Beverly Orsak, Fernando Bril, et al.. (2016). Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus. Annals of Internal Medicine. 14 indexed citations
3.
Cusi, Kenneth, Beverly Orsak, Fernando Bril, et al.. (2016). Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus. Annals of Internal Medicine. 165(5). 305–315. 737 indexed citations breakdown →
4.
Portillo-Sánchez, Paola, Fernando Bril, Maryann Maximos, et al.. (2015). High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. The Journal of Clinical Endocrinology & Metabolism. 100(6). 2231–2238. 393 indexed citations breakdown →
5.
Bril, Fernando, Romina Lomonaco, Beverly Orsak, et al.. (2013). Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. Hepatology. 59(6). 2178–2187. 128 indexed citations
6.
Cusi, Kenneth, Zhihui Chang, Romina Lomonaco, et al.. (2013). Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 60(1). 167–174. 193 indexed citations
7.
Lomonaco, Romina, Carolina Ortiz‐Lopez, Beverly Orsak, et al.. (2011). Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology. 55(5). 1389–1397. 356 indexed citations
8.
Lomonaco, Romina, Carolina Ortiz‐Lopez, Beverly Orsak, et al.. (2011). Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. Hepatology. 54(3). 837–845. 67 indexed citations
9.
Hilsabeck, Robin C., Gregory M. Anstead, Amy Webb, et al.. (2010). Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C. Journal of Neuroimmunology. 221(1-2). 53–61. 24 indexed citations
10.
11.
Hilsabeck, Robin C., Amy Webb, & Stephen L. Stern. (2007). Depression and fatigue: Challenging comorbidities in HCV-infected patients. 6(4). 153–159. 2 indexed citations
12.
Webb, Amy, et al.. (2006). A simple index to measure hygiene behaviours. International Journal of Epidemiology. 35(6). 1469–1477. 47 indexed citations
13.
Goldberg, Hilary J., et al.. (2006). Sarcoidosis after treatment with interferon-α: A case series and review of the literature. Respiratory Medicine. 100(11). 2063–2068. 41 indexed citations
14.
Webb, Amy, et al.. (2005). From Surviving to Thriving: The Use of Information and Communication Technology in an Induction Program for Early Career Teachers in Personal Development, Health and Physical Education. Research Online (University of Wollongong). 2005(1). 2636–2643.
15.
Webb, Amy & Marjorie L. McCullough. (2005). Dietary Lignans: Potential Role in Cancer Prevention. Nutrition and Cancer. 51(2). 117–131. 122 indexed citations
16.
Webb, Amy, et al.. (2003). Verbal Dyspraxia and Galactosemia. Pediatric Research. 53(3). 396–402. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Baratta Breakdown of academic impact, for papers by Antonella Mosca Breakdown of academic impact, for papers by Muriel Webb Breakdown of academic impact, for papers by Federico Salomone Breakdown of academic impact, for papers by Rita Manini Breakdown of academic impact, for papers by Mangesh Pagadala Breakdown of academic impact, for papers by Mirja Tiikkainen Breakdown of academic impact, for papers by Jennifer E. Lambert Breakdown of academic impact, for papers by G Smok Breakdown of academic impact, for papers by Elena Paschetta
Rankless by CCL
2026